Clinical Trial Update: A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) [Phase 4]

View source ↗

Summary

Phase 4 study assessing tolerability and safety of converting stable renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• MYFORTIC (MYCOPHENOLIC ACID)
• PREDNISONE (Prednisone)
• Prograf (Tacrolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED